Personalized dosimetry of ¹⁷⁷Lu-DOTATATE: a comparison of organ- and voxel-level approaches using open-access images

Abstract

Lu-DOTATATE (Lutathera ® ) enables targeted radionuclide therapy of neuroendocrine tumors expressing somatostatin receptor type 2. Though patient-specific dosimetry estimates may be clinically important for predicting absorbed dose-effect relationships, there are multiple relevant dosimetry paradigms which are distinct in terms of clinical effort, numerical output and added-value. This work compares three different approaches for 177 Lu-DOTATATE dosimetry, including 1) an organ-level approach based on reference phantom MIRD S-values scaled to patient-specific organ masses (MIRDcalc), 2) an organ-level approach based on Monte Carlo simulation in a patient-specific mesh phantoms (PARaDIM), and 3) a 3D approach based on Monte Carlo simulation in patientspecific voxel phantoms. Method. Serial quantitative SPECT/CT images for two patients receiving 177 Lu-DOTATATE therapy were obtained from archive in the Deep Blue database. For each patient, the serial CT images were co-registered to the first time point CT using a deformable registration technique aided by virtual landmarks placed in the kidney pelves and the lesion foci. The co-registered SPECT images were integrated voxel-wise to generate time-integrated activity maps. Lesions, kidneys, liver, spleen, lungs, compact bone, spongiosa, and rest of body were segmented at the first imaging time point and overlaid on co-registered integrated activity maps. The resultant segmentation was used for three purposes: 1) to generate patient-specific phantoms, 2) to determine organ-level timeintegrated activities, and 3) to generate dose volume histograms from 3D voxel-based calculations. Results. Mean absorbed doses were computed for lesions and 48 tissues with MIRDcalc software. Mean organ absorbed doses and dose volume histograms were obtained for lesions and 6 tissues with the voxel Monte Carlo approach. Lesion-and organ-level absorbed dose estimates agreed within ±26% for the lesions and ±13% for the critical organs, among the different methods tested. Overall good agreement was observed with the dosimetry estimates from the NETTER-1 trial. Conclusions. For personalized 177 Lu-DOTATATE dosimetry, a combined approach was determined to be valuable, which utilized two dose calculation methods supported by a single image processing workflow. In the absence of quantitative imaging limitations, the voxel Monte Carlo method likely provides valuable information to guide treatment by considering absorbed dose non-uniformity in lesions and organs at risk. The patient-scaled reference phantom method also provides valuable information, including absorbed dose estimates for non-segmented organs, and more accurate dose estimates for complex radiosensitive organs including the active marrow. REVISED

The Challenge of Single-Photon Emission Computed Tomography Image Segmentation in the Internal Dosimetry of 177Lu Molecular Therapies

“…Although the fixed threshold method is simple, the appropriate threshold level strongly depends on the signalto-background ratio [52]. What is more, a single value might not be sufficient for every clinically relevant structure in the image [53]. This method is also strongly biased by the acquisition and reconstruction algorithms.…”

Dose Distribution Analysis of Proton Therapy for Medulloblastoma Cancer With Phits 3.24

“…1. A portable computer with specifications: Processor AMD Ryzen The system reference for simulating proton therapy is the Proteus®ONE system with cyclotron S2C2 made by IBA [9].…”

Impact of deep learning‐based multiorgan segmentation methods on patient‐specific internal dosimetry in PET/CT imaging: A comparative study

“…Image segmentation has found various applications in computer vision and has risen in popularity all over the globe. (Multi)organ segmentation is crucial in Monte Carlo (MC)‐based internal/external dosimetry using an anthropomorphic phantom to calculate average organ dose and so‐called organ‐specific S‐values in radionuclide imaging and therapy 5 . Moreover, in radiotherapy treatment planning, accurate delineation of target organs is commonly performed by an expert radiologist and/or radiation oncologist in order to maximize the dose delivered to the tumor and simultaneously minimize the radiation burden to the organs at risk (OARs) 6 .…”